Researchers from the UK have developed a genetic test capable of predicting an individual’s risk of developing childhood myopia. Read more
Orthoptics Australia restructures for the future
Following a successful national conference in Sydney, Orthoptics Australia’s (OA) new president will oversee measures designed to bring the organisation in line with modern corporate governance standards. Read more
Locally developed glaucoma device leads to new Indonesian partnerships
The Lions Eye Institute (LEI) is strengthening its ties with Indonesian researchers following the successful launch of a new glaucoma drainage device produced for only one-tenth of the cost of competing products. Read more
Artificial intelligence used to diagnose uveitis
Artificial intelligence is being used to extract hidden information from retinal images of patients with birdshot uveitis, in a hope it could lead to more timely diagnosis for the rare condition. Read more
Biogen unveils plan to commercialise Eylea and Lucentis generics
Multinational biotech company Biogen has proposed a deal worth up to US$310 million (AU$453 m) to supply biosimilar treatments of Lucentis and Eylea to major global markets, including Australia. Read more
New imaging system corrects for chromatic aberrations
A new imaging system capable of cancelling out the chromatic aberrations present in a person’s eye promises to provide more accurate assessments of both vision and eye health. Read more
Traces of anti-VEGF drugs found in breast milk
Anti-vascular endothelial growth factor (anti-VEGF) drugs have been identified in breast milk, prompting warnings from the researchers that the use of these medications during breastfeeding could affect developing infants. Read more
German manufacturer licenses BHVI algorithms for new device
The Brien Holden Vision Institute (BHVI) has signed a licensing agreement that will see its algorithms for tracking and estimating refractive error incorporated into a world-first instrument for myopia management. Read more
Optometry Giving Sight establishes new board
International charity Optometry Giving Sight (OGS) has announced a new board of directors who will steer the organisation towards new priorities. Read more
FDA clears Novartis’ new treatment for nAMD
Novartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the drug’s comparable results in head-to-head trials with Eylea. Read more